Sudden cardiac death condition shown to have linked genetic variations
· Medical Xpressedited by Sadie Harley, reviewed by Andrew Zinin
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Chief Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
Scientists have found that the "sudden" cardiac death condition related to high-profile deaths or major medical episodes of sports stars including Fabrice Muamba, Christian Erikson and Mark-Vivian Foe, has numerous linked gene variations that highlight a potentially treatable vulnerability.
In a study published in Nature Communications, a multi-disciplinary team of researchers, including scientists from the University of Birmingham, have uncovered new insights into how "spelling mistakes" in our DNA contribute to hypertrophic cardiomyopathy (HCM), a leading cause of sudden cardiac death worldwide.
"Spelling mistakes" in a protein called alpha-actinin-2 or ACTN2 have previously been identified for their role in the disease, but they have not addressed how these errors lead to cardiac arrest. This study found that 17 of the spelling mistakes in ACTN2 are linked to HCM, and that they affected the protein in different ways.
In the study, structural and cell biologists from the University of Birmingham, University of Oxford and the Research Campus Harwell teamed up to investigate 17 mistakes in ACTN2 using a range of experimental methods and found that they affect the protein in several different ways. Some errors made the protein less stable, more likely to clump together, or less able to interact with other molecules.
Different effects across the protein
Researchers have also found that these spelling mistakes have different effects depending on where they are located within ACTN2. In particular, a critical region called the Actin Binding Domain (ABD), which helps ACTN2 interact with other parts of cells and is important for major cell processes, was identified as a key hotspot for changes caused by these spelling mistakes.
Corresponding author Katja Gehmlich, Professor of Molecular Cardiology at the University of Birmingham, commented, "Hypertrophic cardiomyopathy often affects otherwise fit and healthy individuals, and the effects of the condition can be devastating, as seen in the cases of high-profile footballers such as Mark-Vivian Foe who sadly died in competition.
"The findings will help us and other researchers worldwide to find potential ways to address these genetic weaknesses and better understand how these proteins are literally reshaping the hearts of people with this condition."
A framework for genetic testing
Dr. Fiyaz Mohammed, corresponding author and Lecturer at the University of Birmingham, stated, "Several of the experimental approaches used in this study are readily reproducible in other laboratories. We hope this framework will improve the interpretation of genetic test results for ACTN2-associated cardiomyopathies and could be adapted to study disease-causing genetic changes in other heart proteins."
First author Maya Noureddine, Ph.D. candidate at the University of Birmingham, added, "Inherited heart muscle diseases, known as cardiomyopathies, are often associated with sudden cardiac death. These conditions can be caused by genetic changes, like spelling mistakes in the DNA that affect essential heart proteins.
"However, it is challenging to determine whether a particular genetic change is responsible for disease, making it harder to interpret genetic test results for patients and their families.
"Using a range of laboratory techniques, our team has developed a systematic approach which helped identify which genetic changes are most likely to cause disease. We hope that these findings will ultimately support the development of new treatments for HCM and other cardiac diseases."
The findings also highlight the power of interdisciplinary collaboration, with experts from different fields combining their knowledge, technologies, and approaches to tackle a complex problem in cardiovascular disease.
The research is part of a wider set of studies by Professor Gehmlich and collaborators on hypertrophic cardiomyopathy and other genetic conditions that affect the heart.
Publication details
Comprehensive biophysical and structural profiling of alpha-actinin-2 variants reveals mechanistic diversity in hypertrophic cardiomyopathy, Nature Communications (2026). DOI: 10.1038/s41467-026-75392-z
Journal information: Nature Communications
Key medical concepts
Clinical categories
CardiologyClinical genetics Provided by University of Birmingham Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Sudden cardiac death condition shown to have linked genetic variations (2026, July 21) retrieved 21 July 2026 from https://medicalxpress.com/news/2026-07-sudden-cardiac-death-condition-shown.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.